256 related articles for article (PubMed ID: 21176559)
1. [Extracellular signal-regulated protein kinase activation in endometrium with polycystic ovary syndrome and its significance].
Song XR; Zhang HY; Zhang YF; Han YK; Li KJ
Zhonghua Fu Chan Ke Za Zhi; 2010 Oct; 45(10):767-71. PubMed ID: 21176559
[TBL] [Abstract][Full Text] [Related]
2. [Activation and significance of the PI3K/Akt pathway in endometrium with polycystic ovary syndrome patients].
Zhang HY; Zhang YF; Han YK; Xue FX; Zhao XH; Zhang XL
Zhonghua Fu Chan Ke Za Zhi; 2012 Jan; 47(1):19-23. PubMed ID: 22455688
[TBL] [Abstract][Full Text] [Related]
3. Metformin augments the levels of molecules that regulate the expression of the insulin-dependent glucose transporter GLUT4 in the endometria of hyperinsulinemic PCOS patients.
Carvajal R; Rosas C; Kohan K; Gabler F; Vantman D; Romero C; Vega M
Hum Reprod; 2013 Aug; 28(8):2235-44. PubMed ID: 23595973
[TBL] [Abstract][Full Text] [Related]
4. High level of visfatin and the activation of Akt and ERK1/2 signaling pathways are associated with endometrium malignant transformation in polycystic ovary syndrome.
Tian W; Zhang H; Zhang Y; Wang Y; Zhang Y; Xue F; Song X; Zhang H
Gynecol Endocrinol; 2020 Feb; 36(2):156-161. PubMed ID: 31452406
[TBL] [Abstract][Full Text] [Related]
5. [Tyrosine phosphorylation and protein expression of insulin receptor substrate-2 in the adipose tissue from patients with polycystic ovary syndrome].
Qiu HY; Chu YL; Li M; Sun YY; Li HF
Zhonghua Fu Chan Ke Za Zhi; 2005 Feb; 40(2):116-9. PubMed ID: 15840293
[TBL] [Abstract][Full Text] [Related]
6. [Tyrosine phosphorylation and protein expression of insulin receptor substrate-1 in the patients with polycystic ovary syndrome].
Chu YL; Sun YY; Qiu HY; Li HF
Zhonghua Fu Chan Ke Za Zhi; 2004 Mar; 39(3):176-9. PubMed ID: 15130378
[TBL] [Abstract][Full Text] [Related]
7. Immunolocalization of ERK1/2 and p-AKT in normal endometrium, endometrial hyperplasia, and early and advanced stage endometrioid endometrial adenocancer and their prognostic significance in malignant group.
Gungorduk K; Ertas IE; Sahbaz A; Ozvural S; Sarica Y; Ozdemir A; Sayhan S; Gokcu M; Yilmaz B; Sanci M; Inan S; Harma M; Yildirim Y
Eur J Obstet Gynecol Reprod Biol; 2014 Aug; 179():147-52. PubMed ID: 24965996
[TBL] [Abstract][Full Text] [Related]
8. Androgen and estrogen receptors and co-regulators levels in endometria from patients with polycystic ovarian syndrome with and without endometrial hyperplasia.
Villavicencio A; Bacallao K; Avellaira C; Gabler F; Fuentes A; Vega M
Gynecol Oncol; 2006 Oct; 103(1):307-14. PubMed ID: 16677694
[TBL] [Abstract][Full Text] [Related]
9. Deregulation of tissue homeostasis in endometria from patients with polycystic ovarian syndrome with and without endometrial hyperplasia.
Villavicencio A; Bacallao K; Gabler F; Fuentes A; Albornoz J; Casals A; Vega M
Gynecol Oncol; 2007 Feb; 104(2):290-5. PubMed ID: 17030058
[TBL] [Abstract][Full Text] [Related]
10. Insulin resistance in polycystic ovary syndrome is associated with defective regulation of ERK1/2 by insulin in skeletal muscle in vivo.
Rajkhowa M; Brett S; Cuthbertson DJ; Lipina C; Ruiz-Alcaraz AJ; Thomas GE; Logie L; Petrie JR; Sutherland C
Biochem J; 2009 Mar; 418(3):665-71. PubMed ID: 19053948
[TBL] [Abstract][Full Text] [Related]
11. Lifestyle intervention up-regulates gene and protein levels of molecules involved in insulin signaling in the endometrium of overweight/obese women with polycystic ovary syndrome.
Ujvari D; Hulchiy M; Calaby A; Nybacka Å; Byström B; Hirschberg AL
Hum Reprod; 2014 Jul; 29(7):1526-35. PubMed ID: 24842895
[TBL] [Abstract][Full Text] [Related]
12. [Relation between insulin resistance and insulin receptor gene methylation in the endometrium of patients with polycystic ovary syndrome].
Lin Y; Xing FQ; Ou ZY; Liang JL; Wen AM; Chen Y
Nan Fang Yi Ke Da Xue Xue Bao; 2011 May; 31(5):867-70. PubMed ID: 21602145
[TBL] [Abstract][Full Text] [Related]
13. Metformin decreases angiogenesis via NF-kappaB and Erk1/2/Erk5 pathways by increasing the antiangiogenic thrombospondin-1.
Tan BK; Adya R; Chen J; Farhatullah S; Heutling D; Mitchell D; Lehnert H; Randeva HS
Cardiovasc Res; 2009 Aug; 83(3):566-74. PubMed ID: 19414528
[TBL] [Abstract][Full Text] [Related]
14. The association of bone mineral density with insulin resistance in patients with polycystic ovary syndrome.
Noyan V; Yucel A; Sagsoz N
Eur J Obstet Gynecol Reprod Biol; 2004 Aug; 115(2):200-5. PubMed ID: 15262356
[TBL] [Abstract][Full Text] [Related]
15. [Detection and significance of phosphatidylinositol 3-kinase in adipose tissue of polycystic ovary syndrome patients with insulin resistance].
Chu YL; Qiu HY; Sun YY; Li M; Li HF
Zhonghua Fu Chan Ke Za Zhi; 2006 Jul; 41(7):455-8. PubMed ID: 17083810
[TBL] [Abstract][Full Text] [Related]
16. Adiponectin levels in women with polycystic ovary syndrome and severe insulin resistance.
Sepilian V; Nagamani M
J Soc Gynecol Investig; 2005 Feb; 12(2):129-34. PubMed ID: 15695109
[TBL] [Abstract][Full Text] [Related]
17. [The role of extracellular signal-regulated kinase/mitogen-activated protein kinase pathway in multidrug resistance of hepatocellular carcinoma].
Zhu H; Chen XP; Luo SF; Guan J; Zhang WG; Zhang BX; Mao CP
Zhonghua Wai Ke Za Zhi; 2007 Jul; 45(13):917-20. PubMed ID: 17953842
[TBL] [Abstract][Full Text] [Related]
18. [Expression of insulin receptor substrate 1 and phosphorylation of tyrosine in adipose tissue of polycystic ovary syndrome].
Wang ZC; Gu XF; Yang DZ; Kuang JQ
Zhonghua Fu Chan Ke Za Zhi; 2005 Feb; 40(2):120-3. PubMed ID: 15840294
[TBL] [Abstract][Full Text] [Related]
19. Analysis of clinical characteristics in large-scale Chinese women with polycystic ovary syndrome.
Shi Y; Guo M; Yan J; Sun W; Zhang X; Geng L; Xu L; Chen Z
Neuro Endocrinol Lett; 2007 Dec; 28(6):807-10. PubMed ID: 18063948
[TBL] [Abstract][Full Text] [Related]
20. Endometrium in PCOS: Implantation and predisposition to endocrine CA.
Giudice LC
Best Pract Res Clin Endocrinol Metab; 2006 Jun; 20(2):235-44. PubMed ID: 16772154
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
